Welcome to the e-CCO Library Archive!

Filter:
Y-ECCO Literature Review: Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn’s Disease
Source: ECCO News Issue 02/2014
Authors: Anna Testa
Y-ECCO Literature Review: Individualised therapy is more costeffective than dose intensification in patients with Crohn’s Disease who lose response to anti-TNF treatment: A randomised, controlled trial
Source: ECCO News Issue 03/2014
Authors: Katalin E. Müller
Y-ECCO Literature Review: Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum
Source: ECCO News Issue 01/2011
Authors: Jan Wehkamp
Y-ECCO Literature Review: Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Source: ECCO News Issue 01/2011
Authors: James Lee
Y-ECCO Literature Review: Infliximab and complications after colectomy in patients with ulcerative colitis
Source: ECCO News Issue 04/2011
Authors: Gianluca Pellino
Y-ECCO Literature Review: Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s Disease after ileocolonic resection
Source: ECCO News Issue 02/2016
Authors: Paula Sousa
Y-ECCO Literature Review: Influence of ileal pouch anal anastomosis on bone loss in ulcerative colitis patients
Source: ECCO News Issue 03/2011
Authors: Alexander Esser
Y-ECCO Literature Review: Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis
Source: ECCO News Issue 04/2011
Authors: Colin de Haar
Y-ECCO Literature Review: Local barrier dysfunction identifi ed by confocal laser endomicroscopy predicts relapse in infl ammatory bowel disease
Source: ECCO News Issue 01/2012
Authors: Pascal Jullerat
Y-ECCO Literature Review: Loss of infliximab into feces is associated with lack of response to therapy in patients with severe Ulcerative Colitis
Source: ECCO News Issue 04/2015
Authors: Spyros Siakavellas
Y-ECCO Literature Review: Loss of interleukin-10 signaling and infantile Infammatory Bowel Disease – implications for diagnosis and therapy
Source: ECCO News Issue 03/2012
Authors: Donata Lissner
Y-ECCO Literature Review: Maintenance of remission among patients with Crohn’s disease on antimetabolite therapy after infliximab therapy is stopped
Source: ECCO News Issue 04/2011
Authors: Monica Cesarini
Y-ECCO Literature Review: Maternal Inflammatory Bowel Disease has short and long-term effects on the health of their offspring: A multicenter study in Israel
Source: ECCO News Issue 01/2013
Authors: Marco Gasparetto
Y-ECCO Literature Review: Measurement of Fecal Calprotectin improves monitoring and detection of recurrence of Crohn’s disease after surgery
Source: ECCO News Issue 02/2015
Authors: Tom Holvoet
Y-ECCO Literature Review: Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn’s disease
Source: ECCO News Issue 01/2012
Authors: Peter Bossuyt
Y-ECCO Literature Review: Mortality and causes of death in Crohn’s Disease: Results from 20 years of followup in the IBSEN study
Source: ECCO News Issue 02/2014
Authors: Pedro Magalhães-Costa
Y-ECCO Literature Review: Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
Source: ECCO News Issue 02/2013
Authors: Beatrijs Strubbe
Y-ECCO Literature Review: Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
Source: ECCO News Issue 02/2013
Authors: Loris R. Lopetuso
Y-ECCO Literature Review: Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol
Source: ECCO News Issue 03/2012
Authors: Nanne de Boer
Y-ECCO Literature Review: Ozanimod induction and maintenance treatment for Ulcerative Colitis
Source: ECCO News Issue 03/2016
Authors: Jonathan Segal